Steroid sulfatase explained

Steryl-sulfatase
Ec Number:3.1.6.2
Cas Number:9025-62-1

Steroid sulfatase (STS), or steryl-sulfatase (EC 3.1.6.2), formerly known as arylsulfatase C, is a sulfatase enzyme involved in the metabolism of steroids. It is encoded by the STS gene.[1]

Reactions

This enzyme catalyses the following chemical reaction

3β-hydroxyandrost-5-en-17-one 3-sulfate + H2O

\rightleftharpoons

3β-hydroxyandrost-5-en-17-one + sulfate

Also acts on some related steryl sulfates.

Function

The protein encoded by this gene catalyzes the conversion of sulfated steroid precursors to the free steroid. This includes DHEA sulfate, estrone sulfate, pregnenolone sulfate, and cholesterol sulfate, all to their unconjugated forms (DHEA, estrone, pregnenolone, and cholesterol, respectively).[2] [3] The encoded protein is found in the endoplasmic reticulum, where it is present as a homodimer.[1]

Clinical significance

A congenital deficiency in the enzyme is associated with X-linked ichthyosis, a scaly-skin disease affecting roughly 1 in every 2,000 to 6,000 males.[4] [5] The excessive skin scaling and hyperkeratosis is caused by a lack of breakdown and thus accumulation of cholesterol sulfate, a steroid that stabilizes cell membranes and adds cohesion, in the outer layers of the skin.

Genetic deletions including STS are associated with an increased risk of developmental and mood disorders (and associated traits), and of atrial fibrillation or atrial flutter in males.[6] Both steroid sulfatase deficiency and common genetic risk variants within STS may confer increased atrial fibrillation risk.[7] Cardiac arrhythmia in STS deficiency may be related to abnormal development of the interventricular septum or interatrial septum.[8] Blood-clotting abnormalities may occur more frequently in males with XLI and female carriers.[9] Knockdown of STS gene expression in human skin cell cultures affects pathways associated with skin function, brain and heart development, and blood-clotting that may be relevant for explaining the skin condition and increased likelihood of ADHD/autism, cardiac arrhythmias and disorders of hemostasis in XLI.[10]

Steroid sulfates like DHEA sulfate and estrone sulfate serve as large biologically inert reservoirs for conversion into androgens and estrogens, respectively, and hence are of significance for androgen- and estrogen-dependent conditions like prostate cancer, breast cancer, endometriosis, and others. A number of clinical trials have been performed with inhibitors of the enzyme that have demonstrated clinical benefit, particularly in oncology and so far up to Phase II.[11] The non-steroidal drug Irosustat has been the most studied to date.

Inhibitors

Inhibitors of STS include irosustat, estrone sulfamate (EMATE), estradiol sulfamate (E2MATE), and danazol.[12] [13] The most potent inhibitors are based around the aryl sulfamate pharmacophore[14] and it is thought that such compounds irreversibly modify the active site formylglycine residue of steroid sulfatase.

Names

Steryl-sulfatase is also known as arylsulfatase, steroid sulfatase, sterol sulfatase, dehydroepiandrosterone sulfate sulfatase, arylsulfatase C, steroid 3-sulfatase, steroid sulfate sulfohydrolase, dehydroepiandrosterone sulfatase, pregnenolone sulfatase, phenolic steroid sulfatase, 3-beta-hydroxysteroid sulfate sulfatase, as well as by its systematic name steryl-sulfate sulfohydrolase.[15] [16] [17]

See also

Further reading

Notes and References

  1. Web site: Entrez Gene: STS steroid sulfatase (microsomal), arylsulfatase C, isozyme S.
  2. Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA . The Regulation of Steroid Action by Sulfation and Desulfation . Endocrine Reviews . 36 . 5 . 526–63 . October 2015 . 26213785 . 4591525 . 10.1210/er.2015-1036 .
  3. Rižner TL . The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases . Frontiers in Pharmacology . 7 . 30 . 2016 . 26924986 . 4757672 . 10.3389/fphar.2016.00030 . free .
  4. Alperin ES, Shapiro LJ . Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and function of the steroid sulfatase protein . The Journal of Biological Chemistry . 272 . 33 . 20756–63 . August 1997 . 9252398 . 10.1074/jbc.272.33.20756 . free .
  5. Ghosh D . Mutations in X-linked ichthyosis disrupt the active site structure of estrone/DHEA sulfatase . Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease . 1739 . 1 . 1–4 . December 2004 . 15607112 . 10.1016/j.bbadis.2004.09.003 .
  6. Brcic L, Underwood JF, Kendall KM, Caseras X, Kirov G, Davies W . Medical and neurobehavioural phenotypes in carriers of X-linked ichthyosis-associated genetic deletions in the UK Biobank . Journal of Medical Genetics . 57 . 10 . 692–698 . Mar 2020 . 32139392 . 10.1136/jmedgenet-2019-106676 . 7525778 . free .
  7. Wren G, Baker E, Underwood J, Humby T, Thompson A, Kirov G, Escott-Price V, Davies W . Characterising heart rhythm abnormalities associated with Xp22.31 deletion . Journal of Medical Genetics . 60. 7. 636–643. November 2022 . 36379544 . 10.1136/jmg-2022-108862 . 10359567 . free .
  8. Wren GH, Davies W . Cardiac arrhythmia in individuals with steroid sulfatase deficiency (X-linked ichthyosis): candidate anatomical and biochemical pathways . Essays in Biochemistry . April 2024 . 38571328 . 10.1042/EBC20230098 . free .
  9. Brcic L, Wren GH, Underwood JF, Kirov G, Davies W . Comorbid Medical Issues in X-Linked Ichthyosis . JID Innovations: Skin Science from Molecules to Population Health . 2 . 3 . 100109 . May 2022 . 35330591 . 8938907 . 10.1016/j.xjidi.2022.100109 .
  10. McGeoghan F, Camera E, Maiellaro M, Menon M, Huang M, Dewan P, Ziaj S, Caley MP, Donaldson M, Enright AJ, O'Toole EA . RNA sequencing and lipidomics uncovers novel pathomechanisms in recessive X-linked ichthyosis . Frontiers in Molecular Biosciences . 10 . 1176802 . 2023 . 37363400 . 10285781 . 10.3389/fmolb.2023.1176802 . free .
  11. Potter BV . SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects . Journal of Molecular Endocrinology . 61 . 2 . T233–T252 . August 2018 . 29618488 . 10.1530/JME-18-0045 . free .
  12. Thomas MP, Potter BV . Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential . The Journal of Steroid Biochemistry and Molecular Biology . 153 . 160–9 . September 2015 . 25843211 . 10.1016/j.jsbmb.2015.03.012 . 24116740 .
  13. Carlström K, Döberl A, Pousette A, Rannevik G, Wilking N . Inhibition of steroid sulfatase activity by danazol . Acta Obstetricia et Gynecologica Scandinavica Supplement . 123 . 107–11 . 1984 . 6238495 . 10.3109/00016348409156994 . 45817485 .
  14. Thomas MP, Potter BV . Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health . Journal of Medicinal Chemistry . 58 . 19 . 7634–58 . October 2015 . 25992880 . 5159624 . 10.1021/acs.jmedchem.5b00386 .
  15. Roy AB . The steroid sulphatase of Patella vulgata . Biochimica et Biophysica Acta . 15 . 2 . 300–1 . October 1954 . 13208702 . 1274509 . 10.1016/0006-3002(54)90078-5 .
  16. Book: Roy AB . The Synthesis and Hydrolysis of Sulfate Esters . Advances in Enzymology and Related Areas of Molecular Biology . Advances in Enzymology and Related Subjects of Biochemistry . Advances in Enzymology - and Related Areas of Molecular Biology . 22 . 205–35 . 1960 . 10.1002/9780470122679.ch5 . 13744184 . 9780470122679 .
  17. Halkerston ID, Hillman J, Stitch SR . The enzymic hydrolysis of steroid conjugates. I. Sulphatase and β-glucuronidase activity of molluscan extracts . The Biochemical Journal . 63 . 4 . 705–10 . August 1956 . 13355874 . 1216242 . 10.1042/bj0630705 .